Glaxo’s ViiV Healthcare tussles with Kazakhstan over an AIDS drug

July 5, 2019 |
The Growing Toll of the Global Gag Rule
High price delays introduction of new TB prevention therapy
Related Posts
Access to Medicines

New ViiV license with the ...
Our Story

Brian Macharia Joins Healt...
Access to Medicines

South Africa and India’s...